FAT1 is a target antigen in a subset of de novo allograft membranous nephropathy associated with antibody mediated rejection

Affiliations

• ¹ Division of Anatomic Pathology, Department of Laboratory Medicine and Pathology, Mayo Clinic College of Medicine and Science, Rochester, Minnesota, USA. Electronic address: sethi.sanjeev@mayo.edu.
• ² Mayo Clinic Proteomics Core, Mayo Clinic, Rochester, Minnesota, USA.
• ³ Division of Pulmonary and Critical Care, Department of Medicine, Mayo Clinic College of Medicine and Science, Rochester, Minnesota, USA; Division of Nephrology and Hypertension, Department of Medicine, Mayo Clinic College of Medicine and Science, Rochester, Minnesota, USA.
• ⁴ Division of Anatomic Pathology, Department of Laboratory Medicine and Pathology, Mayo Clinic College of Medicine and Science, Rochester, Minnesota, USA.
• ⁵ Sorbonne Université, Université Pierre et Marie Curie Paris 06, Paris, France; Institut National de la Santé et de la Recherche Médicale, Unité Mixte de Recherche S 1155, Paris, France.
• ⁶ Division of Pulmonary and Critical Care, Department of Medicine, Mayo Clinic College of Medicine and Science, Rochester, Minnesota, USA.
• ⁷ Division of Nephrology and Hypertension, Department of Medicine, Mayo Clinic College of Medicine and Science, Rochester, Minnesota, USA.
• ⁸ Department of Pathology and Laboratory Medicine, Cedars-Sinai Medical Center, Los Angeles, California, USA.
• ⁹ Division of Nephrology, Centre Hospitalier du Mans, Le Mans, France.
• ¹⁰ Department of Pathology and Cell Biology, Columbia University Irving Medical Center, New York, New York, USA.